. On binding to DNA, cGAS is activated to catalyse the synthesis of cyclic GMP-AMP (cGAMP) from GTP and ATP
The atomic models of dimeric full-length chicken STING bound to cGAMP (from ref. 12 ) and the human TBK1 dimer (RCSB Protein Data Bank (PDB) code 4IM0) were fit into the maps (grey) through rigid-body docking. The extra density that surrounds the transmembrane (TM) domain of STING in a is from the detergent micelle. The protein density in b is stronger and therefore shown at a higher threshold, which led to a partial cut-off of the detergent micelle density. c, High-resolution 3D reconstruction from focused refinement on TBK1 with C2 symmetry. The densities for the two protomers of the TBK1 dimer are coloured cyan or blue. The densities for the two STING tails are coloured yellow or green. d, Atomic model of TBK1 bound to the C-terminal tail of STING. The colour scheme is the same as that of the atomic models in a. KD, kinase domain; ULD, ubiquitin-like domain. e, Cartoon model of the STING-TBK1 complex. The double-headed arrow indicates the wobble between TBK1 and STING, owing to flexibility in the STING tail. ER, endoplasmic reticulum.
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and this is not accounted for by residues from TBK1 ( Fig. 1c, Extended  Data Fig. 3) . The high quality of the density allowed us to assign it, on the basis of the shape and size of side chains, to a segment (residues 369-377; corresponding to the same residue numbers in human STING) of the C-terminal tail of chicken STING (Fig. 1d, Extended Data Fig. 3 ). We therefore define this segment as the TBK1-binding motif (TBM). A complete model of the STING-TBK1 complex, based on the structures of the TBK1-STING-TBM complex as well as full-length STING, suggests that the TBK1 dimer is tethered to the two C-terminal TBMs from the STING dimer, whereas the LBD of STING makes little or no contact with TBK1 (Fig. 1e) . The approximately 20-residue linker between the TBM and the final helix in the LBD of STING is disordered in both the crystal structures and the cryo-EM maps of STING, which explains the flexibility between STING and TBK1.
The TBM in STING adopts an extended conformation that is similar to a β-strand, and makes numerous interactions with TBK1 ( Fig. 2a-c,  Supplementary Video 1) . Residues 373-376 in the binding motif are wedged into a groove between the kinase domain from one subunit and the SDD from the second subunit in the same TBK1 dimer. One side of the groove is formed by the N-terminal extension (residues 1-12) and the loop that connects strands β2 and β3 (residues 28-33) in the kinase domain of TBK1; the other side of the groove is lined by the N-terminal end of the third helix in the SDD (residues 577-585) (Fig. 2d) . The side chain of Leu374 in STING sticks into a deep hydrophobic pocket in the middle of the groove. The hydrophobic pocket is formed by Ile582 and Phe585 from the SDD, and Leu8, Arg27 and Gly32 from the kinase domain. This interaction probably makes a major contribution to the binding affinity between STING and TBK1. The two proline residues in the TBM of STING-Pro371 and Pro373-also make hydrophobic interactions with TBK1, by packing with Phe585 in the SDD and Lys30 in the kinase domain, respectively. Arg375 in the STING TBM forms a cation-π interaction with Tyr577 in the SDD. Asp377 in the TBM is located close to Arg375 and may stabilize the side-chain conformation of Arg375. At the other end of the TBM, Asp369 may contribute to the binding by forming electrostatic interactions with Arg405 from the SDD. In addition, the backbone of STING TBM forms several hydrogen bonds with residues in the groove in TBK1, including the side chains of Asn578 and Gln581 in the SDD and the carbonyl oxygen of Lys29 in the kinase domain (Fig. 2c, d) . Luciferase activity was determined 24 h after transfection. Data are mean ± s.d. ***P < 0.001 by two-tailed Student's t-test. h, i, Mutations of interface residues in either STING (h) or TBK1 (i) abolish cGAMP-stimulated phosphorylation (p) of TBK1, STING and IRF3. Cells used in h and i are similar to those in f and g, respectively, except the cells in h and i do not have the IFNβ-luciferase reporter. Cells were treated with cGAMP (1 μM) for 3 h, and subjected to immunoblotting analyses. Data in f-i are representative of three independent biological replicates.
The residues in the TBM are conserved among STING from different species, and constitute a sequence motif of (D or E)XPXPLR(S or T)D (in which X denotes any amino acid) (Fig. 2b) . The side chains of the two non-conserved residues, Leu370 and Gln372 in chicken STING, point away from TBK1 and do not contribute to the binding interface. Residues that form the STING-binding groove in TBK1 are identical between human and chicken TBK1 (Extended Data Fig. 5 ).
We used a pull-down assay with purified STING and TBK1 proteins to verify the mode of binding that was seen in the structure. The results showed that both the L374A mutant of human STING and the Q581A mutant of human TBK1 abolished the STING-TBK1 interaction in vitro, and this appeared to be largely independent of cGAMP ( Fig. 2e) . Further interface mutants of human STING (P371Q, L374A, R375A and L374A/R375A) were tested in a cell-based functional assay (Fig. 2f) . cGAMP treatment led to robust expression of IFNβ in the cells that expressed wild-type STING, but not in cells that expressed each of the mutants (Fig. 2f) . Consistently, cGAMP-induced phosphorylation of TBK1, STING and IRF3 in these cells was abrogated by the interface mutations of STING (Fig. 2h) . We also tested substitutions of interface residues in TBK1 (Y577A, N578A and Q581A) with a similar assay. Cells that expressed each of the interface mutants of TBK1 showed lower levels of cGAMP-induced expression of IFNβ than cells that expressed the wild-type protein (Fig. 2g) . Similarly, cGAMPinduced phosphorylation of TBK1, STING and IRF3 was reduced by the interface mutations in TBK1 (Fig. 2i ). These results demonstrate that the interface residues on both STING and TBK1 are essential for their signalling functions.
We next examined the binding between STING and TBK1 by coimmunoprecipitation from cells. The results showed that there is a constitutive interaction between STING and TBK1 in the absence of cGAMP (Fig. 3a, b) . Indeed, even the STING(R238A/Y240A) mutant that is incapable of binding to cGAMP could bind TBK1. cGAMP stimulation led to phosphorylation of TBK1 and STING, and also enhanced the binding between TBK1 and STING (Fig. 3a, b) . The interface mutants of either STING or TBK1 diminished the binding between the two proteins. To examine the binding in intact cells, we performed immunostaining of transiently expressed STING in HeLa cells that are deficient in cGAS. As has previously been shown 6 , cGAMP stimulates puncta formation of STING at the perinuclear region; this indicates the oligomerization of STING and its translocation from the endoplasmic reticulum to a perinuclear compartment (Fig. 3c ). TBK1 colocalized with these STING puncta, presumably through cGAMP-induced interaction with STING. 
As expected, STING puncta were not affected by the interface mutants of STING (Fig. 3c) . However, the recruitment of TBK1 to STING puncta was not observed in cells that expressed the interface mutants of STING. We also tested interface mutants of TBK1 by co-expressing them with STING in HEK293T TBK1-null cells. Colocalization with STING puncta was detected for wild-type TBK1, but not the mutants (Fig. 3d) . These results further verify the binding interface between STING and TBK1, as seen in our structure. Notably, the results here show that the interaction between STING and TBK1 is enhanced by cGAMP, in contrast to our in vitro binding assays that showed that this interaction is independent of cGAMP ( Fig. 2e , Extended Data Fig. 1a ). This discrepancy suggests that cGAMP regulates the STING-TBK1 interaction in cells through an indirect mechanism.
The structure of TBK1 in complex with STING is indistinguishable from the apo TBK1 structures, which indicates that STING does not activate TBK1 by inducing a conformational change in the kinase domain. The activity of TBK1 is regulated by the phosphorylation of a serine residue (Ser172) in the activation loop [14] [15] [16] . Owing to geometric constraints, the kinase domain normally cannot phosphorylate the activation loop in cis. In addition, the two kinase domains in the TBK1 dimer face away from one another, and therefore cannot phosphorylate Ser172 for each other. One way to achieve activation of TBK1 is through higher-order oligomerization, which brings multiple TBK1 dimers together for trans-autophosphorylation of the activation loop 14 .
In the accompanying paper 12 , we found that full-length STING bound to cGAMP forms a side-by-side tetramer that could grow further Letter reSeArCH into larger oligomers. Therefore, the binding of TBK1 to STING oligomers provides a mechanism for inducing clustering and transautophosphorylation of TBK1 (Fig. 4b) . cGAMP-induced STING oligomerization also provides a model for STING phosphorylation by TBK1. The major phosphorylation site in both human and chicken STING is Ser366 (ref.
11
) (Fig. 2b) , which is not resolved in the cryo-EM map; however, the position of this serine is restrained because it is located only three residues upstream of the TBM (Figs. 2b, 4a) . On the basis of our analysis, Ser366 is estimated to be over 30 Å away from the active sites of the two kinase domains in the TBK1 dimer (Fig. 4a) . Therefore, the tail of STING that is bound to TBK1 cannot be phosphorylated by the same TBK1 dimer to which it is bound. However, in large oligomers of STING, the TBK1 that is tethered to the two C-terminal tails of one STING dimer can phosphorylate Ser366 of neighbouring STING proteins that are not bound to TBK1 (Fig. 4b) . The approximately 20-residue linker between the LBD and Ser366 can span a distance of 60 Å, which is sufficient for Ser366 to reach the active site of TBK1 when it is bound to a neighbouring STING.
To test this model of TBK1 activation and STING phosphorylation, we established an in vitro phosphorylation assay in which the postnuclear S1 fraction of HEK293T cells, which contains STING and TBK1, was incubated with ATP and cGAMP. The results showed that cGAMP induced the oligomerization of STING, and phosphorylation of both TBK1 and STING ( Fig. 4c-f ). As expected, STING(1-341)-which lacks the TBK1-binding tail-formed higher-order oligomers but failed to trigger phosphorylation of TBK1 and STING ( Fig. 4c-f) . The P371Q and L374A mutants of STING, which cannot bind TBK1, also could not stimulate phosphorylation of TBK1 or STING (Extended Data Fig. 6a-c) . STING(139-end), which lacks the transmembrane domain, did not oligomerize or induce TBK1 phosphorylation (Fig. 4c-f ).
In the accompanying paper 12 , we identify the α2-α3 loops of the LBD in each STING dimer that form the tetramer interface. Single or double mutants of two of the tetramer interface residues (Q273A, A277Q and Q273A/A277Q) greatly reduced cGAMP-induced phosphorylation of TBK1, STING and IRF3, as well as reducing the induction of IFNβ (Fig. 4g, h ). In addition, native polyacrylamide gel electrophoresis (native PAGE) revealed that the mutants reduced the formation of higher-order STING oligomers (Fig. 4i) . Similar results were also obtained using the in vitro assay in which cGAMP was added to lysates from HEK293T cells that expressed wild-type STING or the interface mutants (Extended Data Fig. 6d-f) . Notably, the higher-order oligomers of STING were phosphorylated more efficiently than the dimer (compare Extended Data Fig. 6e, f) . Collectively, these results support a model in which the oligomerization of STING is critical for TBK1 activation and STING phosphorylation.
Our analyses suggest a model in which cGAMP-induced, high-order oligomerization of STING provides a signalling platform for recruiting and activating TBK1 (Extended Data Fig. 7 ). In the STING oligomer, some of the C-terminal tails recruit TBK1, which phosphorylates the tails from neighbouring STING molecules. The phosphorylated 363 LXIS 366 motif in STING constitutes an IRF3-binding motif, which recruits IRF3 for phosphorylation by TBK1 11, 17 . The phosphorylated tail of STING may engage TBK1 and IRF3 simultaneously, thereby delivering IRF3 to TBK1 for phosphorylation.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-019-1000-2.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment. Protein expression and purification. The expression and purification of both human and chicken STING proteins are described in the accompanying paper 12 . Human TBK1 fused to T6SS secreted immunity protein 3 (Tsi3) from Pseudomonas aeruginosa at the C terminus was expressed and purified, as described for Tsi3-tagged STING in the accompanying paper 12 . The first step of the purification was based on the high-affinity interaction between the Tsi3 tag and the T6SS effector protein Tse3 conjugated to sepharose 4B resin 18 . Human TBK1 with a C-terminal Flag tag (TBK1-Flag) in the pTY-TBK1 D135N-Flag-puro vector for cryo-EM analyses was expressed in Expi293F cells (Gibco by Life Technologies), cultured in Expi293 expression medium at 37 °C under 8% CO 2 in an incubator shaker (Eppendorf). These and other cells used in the study were assumed to be authentic as they were purchased from commercial sources, and therefore were not independently authenticated. Cells were routinely checked to ensure that there was no mycoplasma contamination by using methods such as DAPI staining and the e-Myco Mycoplasma PCR Detection Kit (Bulldog Bio). When the cell density reached 2.5 × 10 6 cells/ml with >95% viability, the TBK1 plasmid was transfected into the cells. For 1 litre of cell culture, 1 mg of plasmid was gently mixed with 2.7 ml of polyethylenimine (PEI, 1 μg/μl) (Polyscience, 25 kDa, linear) in 50 ml Opti-MEM I reduced serum medium for 20 min before transfection. Thirty-six hours after transfection, cells were collected and resuspended in a lysis buffer containing 25 mM Tris pH 7.5, 300 mM NaCl and protease inhibitor cocktails (Roche). After sonication on ice, the suspension was centrifuged at 1,000g. The supernatant was supplemented with 0.5% (w/v) n-dodecyl-β-d-maltopyranoside (DDM, Anagrade), incubated at 4 °C for 1 h and then centrifuged at 21,000g for 20 min. The TBK1-Flag protein in the supernatant was captured by anti-Flag M2 affinity gel (Sigma) and eluted with Flag peptide (Sigma) at 200 μg/ml in a buffer containing 25 mM Tris pH 7.5 and 300 mM NaCl. The protein was further purified on a Superdex 200 Increase 10/300 column (GE Healthcare). To reconstitute the TBK1-STING complex, TBK1, STING and cGAMP at a 1:3:3 molar ratio were mixed in a buffer containing 25 mM Tris pH 7.5, 150 mM NaCl and 0.03% DDM/ CHS solution (Anagrade), and incubated on ice overnight. The complex was purified on a Superdex 200 Increase 10/300 column (GE Healthcare). Peak fractions were concentrated and kept at −80 °C for cryo-EM studies. Cryo-EM data collection. The STING-TBK1 complex samples (4.5 mg/ml) were applied to a glow-discharged Quantifoil R1.2/1.3 300-mesh gold holey carbon grid (Quantifoil, Micro Tools). Grids were blotted under 100% humidity at 4 °C and plunged into liquid ethane using a Mark IV Vitrobot (FEI). Initial screening showed that particles of the hybrid complex between human TBK1 and chicken STING were much more homogenous than the complex of human TBK1 and human STING. The hybrid complex was therefore chosen for automated micrograph acquisition using the EPU software (FEI) on a Titan Krios microscope (FEI) operated at 300 kV. The K2 Summit direct electron detector (Gatan) was set to the super-resolution counting mode, with the super-resolution pixel size of 0.535 Å. The GIF-Quantum energy filter was set to a slit width of 20 eV. Micrographs were dose-fractioned into 30 frames with a total exposure dose of 48 e − per pixel. Image processing and 3D reconstruction. Motion correction with twofold binning (1.07 Å per pixel), and dose-weighting and CTF correction were conducted using the Motioncorr2 and Gctf programs, respectively 19, 20 . RELION 2.0 was used for all of the following image-processing steps 21 . Approximately 1,000 particles picked from several micrographs were subjected to 2D classification; these were chosen as templates for automated particle picking from the entire dataset of 2,671 micrographs. Particles were extracted and binned fourfold, which resulted in a pixel size of 4.28 Å. Two-dimensional classification of particles clearly showed that the relative orientation between STING and TBK1 was highly variable. Particles belonging to good 2D classes were chosen for 3D classification using an initial model generated from a subset of the particles. Three of the total of eight 3D classes were identified as the STING-TBK1 complex. Owing to the substantial differences in the relative orientation between the two proteins in these 3D classes, only one class showing high-resolution features was selected for subsequent 3D refinement. Particles from this class were re-extracted to the original pixel size of 1.07 Å. Threedimensional refinement and post-processing led to a reconstruction at an overall resolution of 4.4 Å. The density for TBK1 in the reconstruction was of relatively high resolution, whereas that for STING was of low resolution.
A focused reconstruction for TBK was carried out on the basis of the reconstruction of the STING-TBK1 complex. Particles were re-picked on the basis of the references with TBK1 density centred in the middle of the box. One class that showed clear secondary structural features of TBK1 was selected after 3D classification. Subsequent 3D refinement and post-processing with C2 symmetry imposed led to a reconstruction at a resolution of 3.3 Å. The map was of high quality and was used for model building.
Model building, refinement and validation. Owing to the poor resolution, no manual model building was conducted on the basis of the reconstruction of the full STING-TBK1 complex. The structures of human TBK1 and chicken STING were fitted into the density by rigid-body docking using Chimera and Coot. Atomic model building of the TBK1-focused reconstruction was initiated by docking the TBK1 structure (PDB code 4IM0), and subsequent manual building in Coot 22 . In principle, the sample might contain a mixture of the TBK1 dimer bound to zero, one or two STING tails, which could not be distinguished in the refined map owing to the C2 symmetry imposed in 3D refinement. If this was the case, the density for the STING TBM would be expected to be weaker than the surrounding residues in TBK1. However, Extended Data Fig. 3 shows that the densities for the STING TBM and the surrounding TBK1 residues are similar, which suggests that-at least in the subset of the particles used for the focused refinement-both of the binding sites in the TBK1 dimer are occupied by the STING TBM. Real-space refinement was carried out using PHENIX, with secondary structure restraints and noncrystallographic symmetry restraints 23 . Model geometries were assessed with MolProbity as a part of the PHENIX validation tools 24 (Extended Data Fig. 8 ). When model building for TBK1 was finished, two areas of strong density remained unaccounted for; after careful inspection of the map, and consideration of the sequence and structure of STING, these were assigned to two copies of the C-terminal-tail segments (residues 369-377) from chicken STING. The final model contains the STING C-terminal and most residues in TBK1. The activation loop (residues 160-174), the C-terminal region (residues 659-729) and a few other loops in TBK1 were not included in the atomic model owing to poor density. Overfitting was tested by refining the model with coordinates randomly shifted by 0.2 Å against one of the half-maps that were calculated from half of the dataset in RELION (half-map 1). Fourier shell correlation (FSC) curves were calculated for the model in relation to half-map 1 and half-map 2, and then compared with the FSC for the summed map. The good agreement between the three curves indicates that there was no overfitting (Extended Data Fig. 8 ). Structures and maps in the figures were rendered with PyMOL (The PyMOL Molecular Graphics System, v.2.0, Schrödinger), Coot or Chimera 22, 25 . The sequence-alignment figure was generated with ESPript 26 .
Constructs for cell-based assays. For transient transfection, STING-Flag and
TBK1-Flag were generated by cloning the coding sequences into the p-CMVFlag-N2 and pTY-Flag-puromycin vectors, respectively. For generating stable cell lines, STING was cloned into the gateway cloning vectors CSII-EF-DEST-IRES-blasticidin or CSII-EF-DEST-IRES-hygromycin, both of which are lentiviral expression vectors. STING was also cloned into the pCDH-CMV-MCS-IRES-puro lentivirus vector. TBK1 was cloned into the pCDH-CMV-MCS-IRES-neo lentivirus vector. Mutations were introduced by Quikchange mutagenesis (Agilent). Antibodies. Rabbit antibodies used in immunoblotting-including anti-STING, pSTING (Ser366), TBK1, pTBK1 (Ser172), pIRF3 (Ser396) and GAPDH antibodieswere purchased from Cell Signaling Technology. Mouse anti-His6 antibody was also from Cell Signaling Technology. Mouse antibody against human TBK1 was obtained from Santa Cruz Biotechnology. Anti-Flag antibody (M2), antitubulin antibody and M2 affinity gel were purchased from Sigma. In vitro binding assays for STING and TBK1. Tsi3-tagged TBK, immobilized on Tse3-conjudated Sepharose 4B resin as mentioned above, was used to pull down full-length STING or STING(1-343) (that is, STING lacking the C-terminal tail), with or without cGAMP bound, in a buffer containing 20 mM Tris pH 8.0, 150 mM NaCl, 1 mM CaCl 2 , 1 mM DTT and 0.02% DDM. His 6 -tagged Tsi3 protein on the same resin was used as a negative control. Resin was washed three times with the same buffer. Proteins that remained on the resin were analysed by western blot. For co-immunoprecipitation experiments with Flag-tagged STING and His 8 -tagged TBK1 (TBK1-His 8 ) (Fig. 2e) , TBK1 contains a D135N substitution at the kinase active site to render it catalytically dead. The STING-Flag protein was first captured on anti-Flag M2 resin in a buffer containing 20 mM Tris pH 7.5, 150 mM NaCl, 1% DDM/CHS (10:1) and protease inhibitor cocktails (Roche). The resin was washed three times using a wash buffer containing 20 mM Tris pH 7.5, 150 mM NaCl and 0.25% DDM/CHS (10:1). TBK1-His 8 was purified with Ni-NTA agarose (Qiagen) using a strategy similar to that for TBK1-Flag purification, except for the elution procedure. TBK1-His 8 protein was incubated with STING bound to antiFlag M2 affinity resin for 3 h at 4 °C and washed three times. The resin was boiled in SDS-loading buffer and analysed by Coomassie blue staining and immunoblotting. Cell culture, transfection and reagent treatment. HEK293T and HeLa cells were from ATCC. HEK293T cells that lack TBK1 and HeLa cells that lack cGAS were generated by CRISPR-Cas9. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (Thermo Fisher Scientific), penicillin and streptomycin (100 IU/ml and 100 μg/ml, respectively, Gibco by Life Technologies) and 1× nonessential amino acids (Gibco by Life Technologies). Endogenous STING expression is undetectable in these cells. Cell lines that stably expressed various forms of STING or TBK1 through lentivirus transduction were selected with 8 μg/ml blasticidin (Thermo Fisher Scientific), 100 μg/ml hygromycin (Alexis Biochemicals) or 2 μg/ml puromycin (Thermo Fisher Scientific), according to the corresponding selection markers of the constructs. Expi293F cells for TBK1 overexpression were grown in Expi293 expression medium (Gibco by Life Technologies). IFNβ-luciferase reporter assay. For expression of the STING wild type and mutant constructs, HEK293T cells that stably expressed the IFNβ-luciferasepuromycin reporter were transiently transfected with STING plasmids. For expression of TBK1 in HEK293T TBK1 knockout cells, the cells were first transfected with STING lentivirus, followed by transfection with TBK1 wild type and mutant lentivirus. The stable cell lines were transiently transfected with IFNB1-luciferase plasmid DNA and stimulated with indicated doses of cGAMP. Cells were stimulated with indicated doses of cGAMP 10 h after transfection. After an additional 14-h incubation, the luciferase assay was performed following the standard protocol (Promega, E1501). Analyses of the STING-TBK1 interaction by immunoprecipitation. To determine STING-TBK1 complex formation in cells, STING-Flag wild type or mutants were transfected into HEK293T cells. After cGAMP (1 μM) stimulation for 1 h, whole-cell lysates were prepared in a lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM Na 3 VO 4 and Roche protease inhibitor set). Cleared supernatants were incubated with anti-Flag (M2) agarose beads (Sigma) at 4 °C for 2 h. Agarose beads were washed three times with the lysis buffer, and co-precipitated proteins were detected by immunoblotting. Alternatively, HEK293T TBK1-null cells that stably expressed STING-Flag were transfected with the TBK1 wild type or mutants, using lentivirus. Cells that stably expressed STING and TBK1 were stimulated with cGAMP (1 μM) for 1 h. The same immunoprecipitation process as described above was performed to determine the interaction of the STING wild type with the TBK1 wild type or mutants. In vitro phosphorylation assay. HEK293T cells that expressed the STING wild type or mutants were collected and resuspended in a lysis buffer containing 20 mM Tris pH 7.4, 5 mM MgCl 2 and protease inhibitor cocktails (Roche). After micro-sonication, the suspension was centrifuged at 1,000g for 5 min to generate the S1 post-nuclear supernatant. Phosphorylation reactions were carried out by incubating the S1 fraction in 20 μl 1× kinase reaction buffer (50mM Tris pH 7.5, 10 mM MgCl 2 , 2 mM DTT, 2mM ATP and 2 μM cGAMP) at 30 °C for 30 min. The samples were then subjected to SDS-PAGE or native PAGE. STING, pSTING and pTBK1 were visualized by immunoblotting with specific antibodies. Analyses of STING oligomerization by native gels. For analysing the STING oligomers in the cell-based assay, HeLa cells that stably expressed human STING wild type or mutants were treated with cGAMP (1 μM) for 1 h. Cells were then resuspended in a buffer containing 20 mM Tris pH 7.4, 5 mM MgCl 2 and protease inhibitor cocktails (Roche) and sonicated. Lysates were centrifuged at 1,000g for 5 min to generate the S1 supernatant. The supernatant in a buffer containing 25 mM Tris pH 7.5, 5 mM MgCl 2 , 1 mM DTT, 1% NP40, 5% glycerol, 80 mM NaCl, 2.5 mM Na 3 VO 4 and protease inhibitor (Roche) was subjected to native PAGE. Immunoblotting was performed with antibodies against STING. For analysing the STING oligomers in the in vitro phosphorylation assay, HEK293 cells that transiently expressed STING wild type or mutants, resuspended in a buffer containing 20 mM Tris pH 7.4, 5 mM MgCl 2 and protease inhibitor cocktails (Roche), were sonicated and centrifuged at 1,000g for 5 min. The S1 supernatant in a buffer containing 50 mM Tris pH 7.5, 10 mM MgCl 2 and 2 mM DTT was mixed with ATP and cGAMP. After the reaction, the samples were extracted with 1% NP40 and subjected to native PAGE, and immunoblotting was performed with antibodies against STING or pSTING. Immunofluorescence microscopy. For high-resolution imaging, indicated HeLa and HEK293T cells with STING and TBK1 expression were grown on cover glasses or four-well glass-bottom chambers (Laboratory-Tek). HeLa cells deficient in cGAS were transfected with the STING wild type or mutants, and stimulated with cGAMP (1 μM) for 1 h. HEK293T TBK1-null cells were stably transfected with the STING wild type, and then with the TBK1 wild type or mutants. These cells were also stimulated with cGAMP (1 μM) for 1 h. Cells were fixed with 4% paraformaldehyde (Electron Microscope Sciences) for 15 min. For immunofluorescence microscopy, fixed cells were incubated with anti-rabbit STING and anti-mouse TBK1 antibodies, followed by incubation with secondary antibodies conjugated with Alexa Fluor 488 nm and 568 nm, respectively (Thermo Fisher Scientific). Confocal images were acquired on a Nikon A1R confocal microscope using a 60× (NA 1.45) objective. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
The cryo-EM map of the TBK1-STING tail complex has been deposited in the Electron Microscopy Data Bank (EMDB) under the accession number EMD-0506. The atomic coordinates of the complex have been deposited in the PDB under the accession number 6NT9. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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Data collection
Confocal Images were taken with the built-in softwares ( NIS-Elements analysis) of Nikon A1R microscope as detailed in Methods. Luciferase activities were measured and generated with CLARIOstar plate reader and software. Cryo-EM data were collected with the EPU package installed on the Titan Krios microscope.
Data analysis
Statistical analysis was performed using using SigmaPlot 10, Graph Pad Prism 8, and Excel. For colocalization analysis, Pearson's correlation coefficient was calculated using Nikon NIS-Elements analysis software, ImageJ (version 1.51n), and Excel. Cryo-EM image processing, structure determination and analyses were carried using standard software packages including Relion, Phenix, Coot, Pymol, Chimera, Motioncorr2, GCTF, Molprobity, and ESPpript.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub All studies must disclose on these points even when the disclosure is negative.
Sample size
For luciferase activity assay, each sample was performed three times independently and read on the same plate. The data collected were normalized and analyzed to get mean and s.d. For quantification of percentages of cells with phenotype of interest, 3 whole-field images (about 40-100 cells totally) were randomly taken throughout the slide of each sample and were repeated with three independent samples. The sample sizes were selected based on power analysis of results from preliminary experiments, which shows that the sample sizes are not only sufficient to obtain desirable significance level (< 0.01) and power (> 90%), but also able to generate highly reproducible results with biological replicates.
Data exclusions CryoEM data were processed in Relion, which excluded low-quality data to reach high-resolution using statistical methods. The exclusion criteria is pre-established as implemented in Relion, a common practice in cryo-EM
Replication
All experiments were confirmed with multiple biological replicates as detailed in Methods or Figure Legends , and the representative results are shown. All attempts at replication were successful, and the results are reproducible.
Randomization The independent biological replicates of samples for imaging were allocated into experimental groups in a random manner. For quantification of percentages of cells with phenotype of interest, images were randomly taken throughout the slide of each sample using DAPI channel to avoid bias in selection of cells with particular phenotypes, before other channels were used for imaging.
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Validation
All the commercial antibodies have been verified by the manufacturers according to the immunoblots and/or images on their websites. All the specie specificity, noisy signaling, and application were also validated with positive and negative controls. Extensive controls were also performed to ensure that there was no crosstalk between channels of imaging. Detailed original raw data with markers were provided in supplementary figure 1.
Eukaryotic cell lines Policy information about cell lines
Cell line source(s)
Cell lines including HEK293T and HeLa were obtained from ATCC (https://www.atcc.org/). Expi293F cells were from Thermo Fisher Scientific.
Authentication
The cell lines used in this study were verified by ATCC and Gibco and monitored for contamination from other cell lines.
Mycoplasma contamination
The cell lines used in this study were free of mycoplasma contamination based on the results of e-Myco Mycoplasma PCR Detection Kit (Bulldog Bio) and were regularly maintained with Normocin (antimicrobial reagent against mycoplasma, bacteria and fungi) (InvivoGen).
Commonly misidentified lines (See ICLAC register)
Name any commonly misidentified cell lines used in the study and provide a rationale for their use.
Palaeontology Specimen provenance
The study did not involve specimen.
Specimen deposition
Dating methods
Tick this box to confirm that the raw and calibrated dates are available in the paper or in Supplementary Information.
Human research participants
Policy information about studies involving human research participants
Population characteristics
The study did not involve human research participants.
Recruitment
ChIP-seq Data deposition
Confirm that both raw and final processed data have been deposited in a public database such as GEO.
Confirm that you have deposited or provided access to graph files (e.g. BED files) for the called peaks.
Data access links
May remain private before publication.
The study did not use ChIP-seq.
Files in database submission
Genome browser session (e.g. UCSC)
Methodology Replicates
Sequencing depth
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Antibodies
Peak calling parameters
Data quality
Software
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology Sample preparation
The study did not use flow cytometry.
Instrument
Software
Cell population abundance The study did not use flow cytometry.
Gating strategy
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
Magnetic resonance imaging
Experimental design
Design type
The study did not use magnetic resonance imaging.
Design specifications
Behavioral performance measures The study did not use magnetic resonance imaging.
Acquisition Imaging type(s)
Field strength
Sequence & imaging parameters
Area of acquisition
Diffusion MRI Used Not used
Preprocessing
Preprocessing software
Normalization
Normalization template
Noise and artifact removal
Volume censoring
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Statistical modeling & inference
Model type and settings
Effect(s) tested
The study did not use magnetic resonance imaging. Functional and/or effective connectivity
Graph analysis
Multivariate modeling and predictive analysis
